Scott R Evans

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. ncbi request reprint A comparison of goodness of fit tests for the logistic GEE model
    Scott Evans
    Department of Biostatistics, Center for Biostatistics in AIDS Research, Harvard School of Public Health, 651 Huntington Avenue, Boston, MA 02115, USA
    Stat Med 24:1245-61. 2005
  2. pmc Peripheral neuropathy in HIV: prevalence and risk factors
    Scott R Evans
    Harvard School of Public Health, 651 Huntington Avenue, Boston, MA 02115, USA
    AIDS 25:919-28. 2011
  3. pmc A randomized trial evaluating Prosaptide for HIV-associated sensory neuropathies: use of an electronic diary to record neuropathic pain
    Scott R Evans
    Harvard School of Public Health, Boston, Massachusetts, United States of America
    PLoS ONE 2:e551. 2007
  4. pmc Simplification of the research diagnosis of HIV-associated sensory neuropathy
    Scott R Evans
    Harvard School of Public Health, Boston, Massachusetts 02115, USA
    HIV Clin Trials 9:434-9. 2008
  5. pmc Peripheral neuropathy in ART-experienced patients: prevalence and risk factors
    Huichao Chen
    Harvard School of Public Health, 651 Huntington Avenue, FXB 607, Boston, MA, 02115, USA
    J Neurovirol 19:557-64. 2013
  6. pmc HIV peripheral neuropathy progression: protection with glucose-lowering drugs?
    Scott R Evans
    Center for Biostatistics in AIDS Research, Department of Biostatistics, FXB 513 Harvard School of Public Health, Boston, MA 02115, USA
    J Neurovirol 18:428-33. 2012
  7. pmc Memantine for AIDS dementia complex: open-label report of ACTG 301
    Yu Zhao
    Harvard School of Public Health, Boston, Massachusetts, USA
    HIV Clin Trials 11:59-67. 2010
  8. pmc Vicriviroc and peripheral neuropathy: results from AIDS Clinical Trials Group 5211
    Tzu Min Yeh
    Harvard School of Public Health, Boston, Massachusetts 02115, USA
    HIV Clin Trials 11:51-8. 2010
  9. ncbi request reprint Selegiline transdermal system (STS) for HIV-associated cognitive impairment: open-label report of ACTG 5090
    Scott R Evans
    Harvard School of Public Health, Boston, Massachusetts, USA
    HIV Clin Trials 8:437-46. 2007
  10. pmc Effects of central nervous system antiretroviral penetration on cognitive functioning in the ALLRT cohort
    Marlene Smurzynski
    Harvard School of Public Health, Department of Biostatistics, Boston, Massachusetts 02115, USA
    AIDS 25:357-65. 2011

Detail Information

Publications11

  1. ncbi request reprint A comparison of goodness of fit tests for the logistic GEE model
    Scott Evans
    Department of Biostatistics, Center for Biostatistics in AIDS Research, Harvard School of Public Health, 651 Huntington Avenue, Boston, MA 02115, USA
    Stat Med 24:1245-61. 2005
    ..We evaluate the performance of each of the statistics with respect to type I error rates and power in a simulation study. Guidance is provided regarding appropriate use of the statistics under various scenarios...
  2. pmc Peripheral neuropathy in HIV: prevalence and risk factors
    Scott R Evans
    Harvard School of Public Health, 651 Huntington Avenue, Boston, MA 02115, USA
    AIDS 25:919-28. 2011
    ....
  3. pmc A randomized trial evaluating Prosaptide for HIV-associated sensory neuropathies: use of an electronic diary to record neuropathic pain
    Scott R Evans
    Harvard School of Public Health, Boston, Massachusetts, United States of America
    PLoS ONE 2:e551. 2007
    ..To examine the efficacy and safety of Prosaptide (PRO) for the treatment of painful HIV-associated sensory neuropathies (HIV-SN)...
  4. pmc Simplification of the research diagnosis of HIV-associated sensory neuropathy
    Scott R Evans
    Harvard School of Public Health, Boston, Massachusetts 02115, USA
    HIV Clin Trials 9:434-9. 2008
    ....
  5. pmc Peripheral neuropathy in ART-experienced patients: prevalence and risk factors
    Huichao Chen
    Harvard School of Public Health, 651 Huntington Avenue, FXB 607, Boston, MA, 02115, USA
    J Neurovirol 19:557-64. 2013
    ..Aging, taller height, protease inhibitor use, and female sex were significant RFs for PN/SPN. The use of statin drugs was significantly associated with lower odds of SPN, and it may prevent progression from no SPN to SPN...
  6. pmc HIV peripheral neuropathy progression: protection with glucose-lowering drugs?
    Scott R Evans
    Center for Biostatistics in AIDS Research, Department of Biostatistics, FXB 513 Harvard School of Public Health, Boston, MA 02115, USA
    J Neurovirol 18:428-33. 2012
    ..21, 3.85), p = 0.009) while use of glucose-lowering drugs (non-insulin) was protective (OR = 0.12, 95 % CI = (0.02, 0.83), p = 0.031). Use of glucose-lowering drugs (non-insulin) may prevent progression from APN to SPN...
  7. pmc Memantine for AIDS dementia complex: open-label report of ACTG 301
    Yu Zhao
    Harvard School of Public Health, Boston, Massachusetts, USA
    HIV Clin Trials 11:59-67. 2010
    ..To evaluate the long-term safety and efficacy of memantine use as treatment of HIV-associated cognitive impairment...
  8. pmc Vicriviroc and peripheral neuropathy: results from AIDS Clinical Trials Group 5211
    Tzu Min Yeh
    Harvard School of Public Health, Boston, Massachusetts 02115, USA
    HIV Clin Trials 11:51-8. 2010
    ..To evaluate the effect of vicriviroc (VCV) on peripheral neuropathy (PN), the most prevalent neurological complication of HIV infection in HIV-1-infected treatment- experienced population...
  9. ncbi request reprint Selegiline transdermal system (STS) for HIV-associated cognitive impairment: open-label report of ACTG 5090
    Scott R Evans
    Harvard School of Public Health, Boston, Massachusetts, USA
    HIV Clin Trials 8:437-46. 2007
    ..To assess the long-term safety (primary aim) and efficacy (secondary aim) of the MAO-B inhibitor Selegiline Transdermal System (STS) for the treatment of HIV-associated cognitive impairment...
  10. pmc Effects of central nervous system antiretroviral penetration on cognitive functioning in the ALLRT cohort
    Marlene Smurzynski
    Harvard School of Public Health, Department of Biostatistics, Boston, Massachusetts 02115, USA
    AIDS 25:357-65. 2011
    ..We assessed the relationship between estimates of antiretroviral therapy penetration into the CNS, using a published ranking system, and neurocognitive status in HIV-positive participants with plasma HIV-1 RNA (vRNA) suppression...
  11. pmc Comparison of direct and indirect measurement of LDL-C in HIV-infected individuals: ACTG 5087
    Scott R Evans
    Harvard School of Public Health, Boston, MA, USA
    HIV Clin Trials 8:45-52. 2007
    ..Triglyceride (TG) levels >400 mg/dL interfere with the accurate determination of low-density lipoproteins (LDL-C) by the Friedewald equation, making it difficult to assess coronary heart disease risk...